Lexogen Successfully Completes Large-Scale Human Primary Cell Next Gen Sequencing Project with Ochre Bio

High-fidelity RNA-Seq data is foundational for Ochre's human discovery platform. Lexogen NGS Services has been a trusted long-term sequencing partner to Ochre Bio delivering high-quality RNA-Seq data from various sample inputs including bio-banked FFPE to micro-organ and primary hepatocyte samples at scale and in time. Lexogen NGS Services operates in accordance with cGLP and mostly rely on proprietary Lexogen technologies which are designed, developed, and manufactured under ISO 13485 in Vienna, Austria. Their expert teams provide state-of-the-art, streamlined, and customizable workflows to deliver the best results across all sample types, including the most challenging. Lexogen's proprietary THOR and pooling technologies enable extraction-free RNA-Seq, high consistency and resolution at scale.

VIENNA, 25/11/2025 (informazione.news - comunicati stampa - scienza e tecnologia)

High-fidelity RNA-Seq data is foundational for Ochre's human discovery platform. delivering high-quality RNA-Seq data from various sample inputs including bio-banked FFPE to micro-organ and primary hepatocyte samples at scale and in time. Lexogen NGS Services operates in accordance with cGLP and mostly rely on proprietary Lexogen technologies which are designed, developed, and manufactured under ISO 13485 in Vienna, Austria . Their expert teams provide state-of-the-art, streamlined, and customizable workflows to deliver the best results across all sample types, including the most challenging. Lexogen's

says Quin Wills, Founder and CEO of Ochre Bio.

says Stephane Barges , CEO of Lexogen.

For nearly 20 years, Lexogen offers comprehensive solutions for   and  , including kits, reagents, bioinformatics, and services  . Lexogen's products are designed and manufactured in Vienna, Austria , and the sequencing services are also delivered from Vienna . The company is ISO 9001 and 1385 certified, and all services are performed in compliance with cGLP and GDPR.

For more information, visit Lexogen website: www.lexogen.com and follow @lexogen.

Email: info@lexogen.com
Tel.: +43 1 345 1212

Logo - https://mma.prnewswire.com/media/2270700/5639471/Lexogen_Logo_RGB_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/lexogen-successfully-completes-large-scale-human-primary-cell-next-gen-sequencing-project-with-ochre-bio-302624499.html